Mark J. Alles
Presently, Mark J. Alles holds the position of President for Acetylon Pharmaceuticals, Inc. He is also on the board of 5 other companies.
He previously held the position of Chairman of Turning Point Therapeutics, Inc., Chairman & Chief Executive Officer for Celgene Corp., Principal at Centocor, Inc., Principal at Bayer Corp. and Vice President-Oncology Business Unit at Aventis Pharmaceuticals, Inc.
Mark J. Alles received an undergraduate degree from Lock Haven University of Pennsylvania.
|05/13/2020||10,000||Acquisition at $8.86 per share.||88,600|